全部文献

iLips®动态唇填充:5年高可重复性技术经验

2026年7月20日28 min read

Aesthetic Plastic Surgery · 2026

iLips®: A 5‑Years Experience with a Highly Reproducible Approach for Dynamic Lip Filler

Authors: Marco Gratteri¹ · Pierluigi Gigliofiorito²,³ · Marco Palmesano⁴,⁵ · Luca Piombino⁶ · Mario D'Anna²,³ · Michele Guariglia²,³ · Lisa Lampis²,³ · Giovanni Francesco Marangi¹ · Valerio Cervelli⁵ · Paolo Persichetti¹

Journal: Aesthetic Plastic Surgery (2026) | DOI: 10.1007/s00266-026-05982-1


Abstract

Background Migration is one of the most feared complications following lip filler. The use of a specific filler with a high degree of elasticity and cohesiveness could be the key to solve the problem if injections are performed in the correct anatomical plane. The purpose of this study was to describe the authors' 5-year experience with a new concept of lip filling, iLips. This reproducible approach combines elasticity and cohesiveness of a 25,5 mg/ml filler injected through superficial micro-tunnels in a virtual space between orbicularis muscle and mucosa creating a tridimensional net that respects lip dynamic also leading to a low risk of filler migration.

Methods A total of 4583 consecutive patients who underwent lip filler with iLips technique were enrolled in this prospective study. An objective evaluation on the aesthetic results was obtained by a jury composed of 3 external plastic surgeons using Lip Fullness Merz scale. PROMs were investigated through FACE-Q administration to the patients ("Psychological function", "Satisfaction with outcome" and "Satisfaction with lips" scales). Statistical analysis was performed through Prism10. Complications were reported.

Results t-test with Welch's correction showed an improvement in Lip Fullness Merz score both in upper and lower lip (p<0.05). A similar trend was shown also for "Psychological function", "Satisfaction with outcome" and "Satisfaction with lips" mean values after the procedure. Just 2 cases of major vascular complications were reported.

Conclusion iLips® seem to be a safe, highly reproducible, effective and satisfying approach for lip augmentation positively impacting also the patient's psychological sphere.

Level of Evidence IV This journal requires that authors assign a level of evidence to each article.

Keywords Lip filler · Dynamic filler · Dermal filler · Lip augmentation · Filler migration


Introduction

Whether an ideal of beauty could be universally accepted, this may regard lips [1]. Voluminous, shaped, smooth and soft lips may be considered not only attractive, but also youthful [2, 3]. With aging, lips lose their initial appearance becoming thinner due to a reduction in collagen and elastin [4]. Dermal fillers for lip enhancement, specifically Hyaluronic acid (HA), represent a valid and safe solution to achieve common beauty standards [5].

With an increasing trend of at least 4% from 2022 to 2023, ASPS statistic considers lip filler as one of the most frequent minimally invasive procedures in cosmetic medicine [6].

Nevertheless, the procedure is not risk-free. Major vascular complications and consequent lip necrosis are among the most fearsome ones [7]. Even filler migration is considered one of the most complained complications [8]. The use of a specific filler with peculiar rheological characteristics and the definition of a correct injection plane could be the key to solve and prevent these undesirable effects.

Following this vision, the purpose of this study was to describe the authors' 5-year experience with a new concept of dynamic lip filling, iLips [9]. This reproducible approach combines elasticity and cohesiveness of a 25,5 mg/ml filler injected through superficial and crossed micro-tunnels within a virtual space between orbicularis muscle and mucosa, creating a tridimensional HA net that respects lip dynamic with a low risk of filler migration. The approach results from a combination of different vertical and horizontal injection techniques that the authors have put together to provide practical guidance on the main steps that injectors can follow to potentially achieve an aesthetic result similar to the authors' one. Data and considerations regarding patient- and plastic surgeon-specific evaluations on the aesthetic results as well as complications were reported.


Methods

Sample Study

A total of 4583 consecutive patients who underwent lip augmentation with iLips technique within 5 years by the same team of plastic surgeons uniformed on the minimally-invasive technique were enrolled in this multicentric case series. Exclusion criteria for the study were: previous lip filler in the last 6 months, previous silicon or other permanent lip filler injections, concomitant other cosmetic procedures, lip tattoo in the last month, uncompensated major comorbidities, diagnosis of psychiatric disorders and of immunological diseases and lack of follow-up (minimum 2 months).

Of the initial 4583 patients, the final sample study was composed of 4312 patients as 271 patients were excluded because of lack of follow-up. Sociodemographic distribution and clinical characteristics of the sample study is illustrated in Table 1.

The average length of the follow-up period was 3,4 months (minimum 2 months, maximum 8 months). As in the authors' daily practice, each patient was asked to come back after two months. Complications were recorded during all the follow-up period, with special attention to filler migration occurrence (diagnosed by the injector through clinical examination and eventually through Ultrasound). Each patient signed a specific consent for research purposes and for photos publication. The study was conducted in accordance with local regulations, international standards of "Good Clinical Practice" in the European Community and the principles of the Declaration of Helsinki.

Table 1 Sociodemographic and clinical characteristics of the sample study (Total sample = 4312 patients)

Sociodemographic / clinicaln%Sociodemographic / clinicaln%
Age rangeBMI
< 35375186,99< 30397892,25
≥ 3556113,01≥ 303347,75
SexKnown allergies
Male230,53Yes56213,03
Female428999,47No375086,97
Marital statusKnown dermatological condition
Single/divorced301869,99Yes2165,01
Not single129430,01No409694,99
OccupationHypertension
Yes419997,38Yes1383,20
No1132,62No417496,80
EducationDiabetes mellitus
Primary education100,23Yes1914,43
Higher education or degree430299,77No412195,57
SmokingPrevious lip filler (>6 months before)
Yes332177,02Yes375186,99
No99122,98No56113,01
Physical activityMajor complications with previous lip filler
Yes375186,99Yes1292,99
No56113,01No418397,01

Objective Evaluation

The objective evaluation was determined by a jury composed of 3 independent plastic surgeons who were uninformed on the aim of this study, on the technique and on the usage of the Merz Lip Fullness Assessment Scale (MLFAS) [10]. This internationally validated scale provides a score ranging from 0 (minimal volume) to 4 (very significant volume) for volume evaluation in both upper and lower lip [10]. All the patients were evaluated by examination of standardized photos of the full face in frontal, oblique and lateral views. Photographs were obtained in the preoperative setting and immediately after the procedure. Position, facial expression, focal distance and camera settings were standardized. Patient age, sex and length of follow-up were also recorded for each patient. The images were presented on PowerPoint slides with each case lasting 30 seconds. The observers were asked to give a score for both upper and lower lip following the above-mentioned scale. An average of the three scores provided by the plastic surgeons was then calculated for each lip.

Subjective Evaluation

The subjective evaluation method consists of an anonymous FACE-Q [11] Aesthetic questionnaire administered to the patients in written form preoperatively and immediately after the procedure. Just 3 scales of this internationally validated questionnaire were chosen: "Psychological function", "Satisfaction with outcome" and "Satisfaction with lips". "Satisfaction with outcome" scale was administered just after the procedure following instruction provided by the Q-portfolio team. Each scale provides a total score for the single patient. This was converted using a RASCH [12] converting scale (provided by the Q-Portfolio team) in a score ranging from 0 to 100 for a better comparison of the results. The authors highlight that this internationally validated questionnaire administration is a routine procedure that they perform also for legal purposes for each injected patient, as well as photographic documentation.

Statistical Analysis

All the data deriving from objective and subjective evaluation were noted in an Excel worksheet and then exported into PRISM 10 for a descriptive statistical analysis. Shapiro–Wilk test was used to determine the possible Gaussian distribution of the values. t-test with Welch's correction was performed to identify any possible significance in changes in MLFAS evaluation. t-test with Welch's correction was used with the same aim for two FACE-Q scales ("Psychological function" and "Satisfaction with lips").

iLips Technique

The patient is assessed in an orthostatic position for a precise analysis of any possible asymmetry in both lips. Caution is exercised in visualising any areas where the labial artery appears to be more superficial (Video 1). Such areas, generally in the wet zone, should be avoided to reduce the risk of vascular complications. A topical anesthetic cream (20% Tetracaine + 5% Prilocaine + 5% Lidocaine) is applied for at least 10 minutes in order to reduce any discomfort. Photographs are taken and lips are then disinfected with an antiseptic alcohol-based solution. A syringe with 1 ml of 25,5 mg/ml cross-linked HA (Hyaluronic Acid) Belotero Intense lidocaine (Merz) is required.

  1. Authors start injecting the upper lip and just after proceed with the lower one. In this vertical technique, injection starts from the Cupid's bow and then proceeds laterally. All the lines cross the vermilion and the filler is placed between the mucosa and orbicularis muscle with a retrograde technique based on 3-4 injection entry points (Fig. 1).

Fig. 1 — First phase of iLips technique. Vertical injections start from the Cupid's bow and then proceed laterally. All the lines cross the vermilion and the filler is placed between the mucosa and orbicularis muscle with a retrograde technique based on 3-4 injection entry points.

  1. Next, parallel linear retrograde injections are performed perpendicular to the vermilion in the lateral portion of the upper lip (Fig. 2).

Fig. 2 — Second phase of the technique. Parallel linear retrograde injections are performed perpendicular to the vermilion in the lateral portion of the upper lip

  1. Injector attention then passes to the lower lip by creating 4-5 vector lines perpendicular to the vermilion restoring volume to the central tubercle (Fig. 3).

Fig. 3 — Third phase of the technique focuses on the lower lip. 4-5 vector lines perpendicular to the vermilion restore the volume into the central tubercle

  1. A fanning technique is now used to restore the volume in the lateral portion with one or two injection entry points (Fig. 4).

Fig. 4 — Fourth phase. A fanning technique is used to restore the volume in the lower lip lateral portion with one or two injection entry points

  1. Last step includes new more nearly horizontal lines in the upper lip to increase lip eversion or to correct any asymmetry, if necessary (Fig. 5).

Fig. 5 — In the last phase new more nearly horizontal lines in the upper lip allows to increase lip eversion or to correct any asymmetry

All the passages of the described technique are shown in Video 2. Patients are given dry ice at the end of the procedure and a glycosaminoglycano polysulphate (GAGPS)-based cream is prescribed to be used up to four times a day if bruising occurs [13]. A gentle massage is performed [14]. Patients are also asked not to eat or drink hot food in the following hours and not to perform intense sports [15].


Results

In this case series 99,47% (4289) of the patients were women and just 0,53% (23) were men. The age ranged from 18 to 54 years. Specifically, 86,99% (3751) of the sample study was composed of patients younger than 35 years old, while just 13,01% (561) patients were older or equal to 35. Average injected volume was 0.85±0.13 cc with a range from 0.65 to 1cc.

Objective and Subjective Evaluation

Subjective evaluation based on FACE-Q showed a high satisfaction with the iLips approach (Figs. 6A, 6B, SDC 1, 2, 3 and 4). Specifically, the mean value of the "Satisfaction with lips" scale rose from 55,18±11,38 to 87,21±11,65. A similar trend is shown with the "Psychological function" scale, in which mean value tended to rise from 77,74±16,88 in the preoperative setting to 86,06±10,45 immediately after the procedure. This trend data may be confirmed by the high result obtained by the "Satisfaction with outcome" scale. This was the only scale administered just in the postoperative setting (due to the nature of the questionnaire).

Fig. 6 — (A) Pre-operative frontal view in a 32 years old patient. (B) Post-operative frontal view in the Figure 6A patient who underwent lip filler with iLips technique

Focusing on the objective evaluation (MLFAS), in all the cases the starting score rose after the procedure for both upper (preoperative minimum value 0 - postoperative minimum value 2) and lower (preoperative minimum value 1 - postoperative minimum value 2) lips.

The other data deriving from patients and surgeons administration of the questionnaire are illustrated in Table 2.

Table 2 Data deriving from objective (MLFAS - Merz Lip Fullness Aesthetic Scale) and subjective (FACE-Q Aesthetic) evaluations

Investigated outcomeMinimumMaximumMeanSD
Upper lip MLFAS (PRE)031,190,86
Upper lip MLFAS (POST)243,370,55
Lower lip MLFAS (PRE)142,190,86
Lower lip MLFAS (POST)243,380,55
Satisfaction with outcome FACE-Q (POST)5210079,2315,12
Satisfaction with lips FACE-Q (PRE)377755,1811,38
Satisfaction with lips FACE-Q (POST)4510087,2111,65
Psychological function FACE-Q (PRE)3010077,7416,88
Psychological function FACE-Q (POST)7110086,0610,45

t-test with Welch's correction was used to identify any possible statistically significant difference in both subjective and objective evaluations. The tests demonstrated that all the above-mentioned improvements were statistically significant with a p<0,05 (Table 3).

Complications

No lip necrosis was detected in this case series. Just 0,05% (2) of the patients experienced a major vascular complication. In one case, the HA was injected too deeply, probably into the labial artery or a nearby vessel. In this case, the injection of hyaluronidase in the previously injected site and in the rest of the lip (500 UI) prevented skin necrosis [16]. In the other case, a possible spasm of the labial artery, which initially caused one side of the lip to turn whitish, was observed. Subsequently, only with intense circular massage did it resolve spontaneously without the use of hyaluronidase. Filler migration was detected in 0,26% (11) of the cases, while two cases (0,05%) of allergic reaction was present in this series. No abscess and persistent swelling over 4 days was detected. Transient erythema (98,01%) was considered a physiological reaction to the injection as well as transient swelling (99,69%). Nine (0,21%) herpetic outbreaks were evidenced in patients who already had this kind of condition. Just three cases (0,07%) of lip discoloration/Tyndall effect were reported. The authors recurred to Hyaluronidase injection in just 8 patients (0,19%) (Table 4).


Discussion

Voluminous, smooth and soft lips may be considered a universally accepted beauty standard [1, 3]. With aging, lips become thinner due to a reduction in collagen and elastin [4]. In the past, the use of permanent silicone fillers seemed to be a solution to the problem [17]. Nowadays a "new" variety of lip augmentation techniques with a lower rate of complications is available [18]. This includes both surgical and non-surgical procedures as: non-filling surgery (lip lift or mucosal advancement [19]) and surgical or non-surgical filling procedures (injectable absorbable fillers, fat grafting and permanent implants [5, 20, 21]). Despite the recent development and spread of indirect lip augmentation techniques, such as the "Cupid lift" described by Talei [22], HA injection seems to remain a valid and safe solution for lip augmentation. Furthermore, one of the dermal filler's advantages is the possibility of lip contouring and asymmetry correction [23]. The minimally-invasive procedure is relatively fast and safe, but not risk-free.

Pre-procedural objective examination and knowledge of anatomy are essential for trying to minimize the complication rate, especially vascular ones [15]. Compression and intravascular injection may potentially lead to ischemia and subsequent necrosis [24]. Ultrasound appears to be a valuable ally for pre-procedural study of the labial artery topographic anatomy [25]. Despite this, complications may occur even in experienced hands, and the promptly use of Hyaluronidase may be the key for resolving the problem [26, 27].

Filler migration is among the most troublesome complications for the patient, but also for the injector [28]. This seems to be due not only to the use of an incorrect injection plan, but also to the usage of a filler with rheological characteristics (cohesivity) that are not suitable for the dynamics of the area [29]. The orbicularis muscle is a very strong concentric muscle that continuously in daily life is contracted during chewing, but also during verbal and nonverbal speech [30].

Table 3 Descriptive statistical analysis results

Compared set of valuesTestSignificant (p<0,05)?
Upper lip MLFAS (PRE) vs Upper lip MLFAS (POST)t-test with Welch's correctionYes
Lower lip MLFAS (PRE) vs Lower lip MLFAS (POST)t-test with Welch's correctionYes
Satisfaction with lips FACE-Q (PRE) vs POSTt-test with Welch's correctionYes
Psychological function FACE-Q (PRE) vs POSTt-test with Welch's correctionYes

Table 4 Complications

Complicationn%
Minor complications
Visible and/or palpable nodule/lump160,37
Granulomatous foreign body reaction00
Discolouration30,07
Transient erythema (within 24 hours)422698,01
Transient swelling (within 4 days)429999,69
Herpetic outbreak90,21
Asymmetries reported by the patient1272,95
Major complications
Filler migration110,26
Visible and/or palpable mass00
Angioedema/Allergic reaction20,05
Abscess00
Persistent erythema (over 24 hours)40,09
Persistent swelling (over 4 days)00
Major vascular complication20,05
Lip necrosis00

Following this vision, intramuscular injection could be one of the causes of filler migration. The authors also point out that the orbicularis muscle may not be the only culprit given as other muscles have insertion points into this aesthetic unit and neighboring anatomical regions.

Since there is no universally accepted injection technique for lip augmentation with dermal fillers, the authors over the years attempted to create a standardized approach, which they named iLips. Based on their experience and on the anatomical concepts described by prestigious authors, the technique was planned in order to provide a low rate of complications while maintaining a high aesthetic quality standard in lip filling. For these reasons, the authors decided to report in this case series their 5-year experience with iLips in more than 4000 consecutive patients undergoing lip fillers by the same team unified on this standardized technique.

The approach the authors previously described is based on three main points:

  1. The choice of a high elasticity and cohesive filler;
  2. The use of crossed superficial micro-tunnels in a virtual space between orbicularis muscle and mucosa;
  3. The creation of a three-dimensional filler net that follows lip dynamic.

The choice of 25.5 mg/ml cross-linked HA (Hyaluronic Acid) Belotero Intense lidocaine (Merz) with a high degree of elasticity [31] (ability of a material to return to its original shape after physical stimulus) and cohesiveness [32] (ability of a product subjected to external pressure not to disintegrate) is mandatory. A filler with a low degree of cohesiveness would tend more to diffuse. Specifically, if the filler would have low cohesiveness, after continuous and repeated physical action of the orbicularis and masticatory muscles, it could not return to the original shape obtained immediately after injection [33]. Belotero Intense is a BDDE (1,4-Butanediol Diglycidyl Ether) cross-linked filler with a polidensified cohesive matrix (CPM) [34]. The gel's lower HA density areas make it easier to inject and allow it to integrate smoothly into all dermal planes. The higher HA density areas allow the gel to create more structural support and, once injected into the right dermal plane, make it more durable [34, 35].

Another aspect that the injector must take into account when using the above-mentioned HA is the "swelling factor". This describes the ability of the HA to expand as it binds water while still maintaining a single phase in vitro [31]. In other words, it is an indication of the degree of the gel's hydration. Belotero Intense has a swelling factor of intermediate degree. Consequently, the injector has to expect and explain to the patient a possible reduction of up to 20% in volume after one week compared to the immediate result. This may be due not only to the swelling factor, but also to the traumatism associated with the various micro-tunnels created during injections.

The choice not to perform boli, but to take advantage of micro-tunnels to create vector lines, was justified by two factors: crossed micro-tunnels created by retrograde injections allow the design of an "elastic" structural network, and in addition, boli could be the basis of obvious and palpable asymmetries that would require Hyaluronidase injection.

The three-dimensional "elastic skeleton" (Fig. 7) potentially expands and contracts in synergy with lip dynamics emphasizing the modern concept of the "dynamic filler" which follows facial expressions [36]. In the modern era, social networks such as Instagram and TikTok have adopted the use of more and more videos and less photos [2]. Cosmetic medicine is also beginning to follow these concepts aiming to "design" lips that are aesthetic not only in photos, but also in videos when facial mimicking muscles are activated (Video 3). So, the aim of the filler is also to create natural results following the aesthetic units' movement in dynamic [37, 38].

Fig. 7 — All the HA micro-tunnels allow the creation of vector lines in order to design an "elastic" structural network. This 3D "elastic skeleton" potentially expands and contracts in synergy with lip dynamics emphasizing the modern concept of the "dynamic filler" which follows facial expressions

Regarding the possibility of filler migrations, authors highlight another strength in the above-described approach: when injecting the filler between the muscle and the mucosa, this has a greater possibility to encounter an "exit obstacle" during smiling [39]. This is represented by a group of fibrous fibers as a "septum" connecting the vermilion to the orbicularis muscle. As previously mentioned, if HA is placed within the muscle, the contraction of the orbicularis muscle would give a push and subsequent filler migration upward [40]. In this case, as there is no longer this natural barrier filtering the product, the HA would migrate onto the prolabium creating an anti-aesthetic effect (swollen prolabium) [41]. These concepts were already described by prestigious authors in scientific literature [3, 8, 18]. Other areas to be avoided for vascular reasons are labial commissures and wet zone [8]. Specifically, the risk of submucosal accumulation on the wet side of the lip is high [42].

iLips does not neglect its primary aim leading to a very satisfactory aesthetic result for the patient (Video 4). As it is illustrated in SDC 5, the average values of the FACE-Q "Satisfaction with lips" tended to increase immediately after the procedure [43]. The trend is similar for "Psychological function", also demonstrating the psychological power of this technique that leads patients to appreciate themselves more and feel better about themselves [44]. The only scale of the FACE-Q that was administered just in the postoperative setting was "Satisfaction with outcome." This scale also showed a very high score and higher scores reflect better outcomes.

Objective evaluation by the jury of plastic surgeons outside the team also demonstrated the effectiveness of the described approach in increasing lip volume (SDC 6).

Focusing on safety, no lip necrosis occurred in this case series. Major vascular complication rate was really low (0,05% of the patients). Also filler migration had a low occurrence rate (0,16%). Transient erythema, as well as transient swelling, was considered a physiological reaction to the procedure. All the three cases of lip discoloration/Tyndall effect were due to a too much superficial malpositioning of filler and required Hyaluronidase injections.

Strength of this study includes the multicentric setting, the use of an internationally validated questionnaire (FACE-Q), the use of an objective evaluation method for lip volume augmentation (MLFAS) and the huge sample of study. Major limitations are the brevity of follow-up and the administration of questionnaires only in the immediate postoperative period. Additional study directions may include increasing the study sample and follow-up period and comparison with other lip augmentation techniques. The authors emphasize that in this research they wanted to standardize the main steps of their approach and to describe and explain the main principles, derived from other researches and their experience, that they adopted in order to allow reproducibility of their approach with one specific HA filler they inject in daily practice. Nevertheless, the procedure should always be adapted to the specific clinical case as lips present highly distinctive morphological and functional characteristics—both in their active and involutive forms—regardless of temporary aesthetic requests from patients.


Conclusion

iLips seem to be a safe, reproducible, effective and satisfying approach for lip augmentation positively impacting the patient's psychological sphere.


References

  1. Loucas R, Sauter B, Loucas M, et al. Is there An "ideal instagram face" for caucasian female influencers? a cross-sectional observational study of facial proportions in 100 top beauty influencers. Aesthet Surg J Open Forum. 2024;6:ojae085.
  2. Harris S, Castellari F, Orlovska M, Othoro D, Bran G. Instagram vs reality: assessment of the representation of lip aesthetic subtypes on social media using the lip classification of tubercles system. Aesthet Surg J Open Forum. 2025;7:ojaf010.
  3. Atiyeh BS, Beaineh PT, Hakim CRA, et al. Lip augmentation with soft tissue fillers: social media, perceptual adaptation, and shifting beauty trends beyond golden standard ideals. Plast Reconstr Surg Glob Open. 2024;12(10):e6238.
  4. Hilton S, Sattler G, Berg AK, Samuelson U, Wong C. Randomized, evaluator-blinded study comparing safety and effect of two hyaluronic acid gels for lips enhancement. Dermatol Surg. 2018;44(2):261–9.
  5. Cooper H, Gray T, Fronek L, Witfill K. Lip augmentation with hyaluronic acid fillers: a review of considerations and techniques. J Drugs Dermatol. 2023;22(1):23–9.
  6. American Society of Plastic Surgeons. 2024 plastic surgery statistics. 2025.
  7. Diwan Z, Trikha S, Etemad-Shahidi S, Parrish N, Rennie C. Evaluation of current literature on complications secondary to lip augmentation following dermal filler injection. J Clin Aesthetic Dermatol. 2023;16(7):26–33.
  8. Kroumpouzos G, Harris S, Bhargava S, Wortsman X. Complications of fillers in the lips and perioral area: Prevention, assessment, and management focusing on ultrasound guidance. J Plast Reconstr Aesthetic Surg JPRAS. 2023;84:656–69.
  9. Gigliofiorito. Filler Labbra - tutto quello che c'è da sapere sull'intervento di medicina estetica più richiesto. Dr Lips - Specialisti in Filler Labbra e Trattamenti Estetici Innovativi. 2020.
  10. Bloom J, Kaplan J, Verma A et al. Development and validation of a photonumeric scale for evaluation of lip fullness. J Drugs Dermatol. 2023;22(3):274-281.
  11. Ottenhof MJ, Veldhuizen IJ, Hensbergen LJV, et al. The use of the FACE-Q aesthetic: a narrative review. Aesthetic Plast Surg. 2022;46(6):2769–80.
  12. Peeters MJ, Augustine JM. Using rasch measurement for instrument rating scale refinement. Curr Pharm Teach Learn. 2023;15(1):110–8.
  13. Polieri T, Orsoni E, Saponati G, Castellacci E. Efficacy and tolerability of clarema 1% cream and hirudoid 40000 U.APTT gel in the topical treatment of haematomas and/or subcutaneous haematic extravasations. ISRN Orthop. 2012;2012(1):504151.
  14. Gigliofiorito P. Come eseguo il massaggio delle labbra dopo un filler? Chirurgia Plastica e Ricostruttiva. 2022.
  15. Urdiales-Gálvez F, Delgado NE, Figueiredo V, et al. Preventing the complications associated with the use of dermal fillers in facial aesthetic procedures: an expert group consensus report. Aesthetic Plast Surg. 2017;41(3):667–77.
  16. DeLorenzi C. New high dose pulsed hyaluronidase protocol for hyaluronic acid filler vascular adverse events. Aesthet Surg J. 2017;37(7):814–25.
  17. Mortada H, Al Saud N, Alaithan B, Alhumsi T. Complications following permanent filler injection: a prospective cohort study and protocol of management. Plast Reconstr Surg Glob Open. 2022;10(11):e4687.
  18. DeJoseph LM, Agarwal A, Greco TM. Lip augmentation. Facial Plast Surg Clin N Am. 2018;26(2):193–203.
  19. Fallahi HR, Keyhan SO, Bohluli B, Cheshmi B, Jafari P. Lip lift techniques in smile design. Dent Clin North Am. 2022;66(3):443–57.
  20. Tabassum N, ChowdaryJasthi V, Al Salem A, et al. Perspectives and challenges in lip rejuvenation: a systematic review. Eur Rev Med Pharmacol Sci. 2023;27(19):9043–9.
  21. Brody-Camp S, Raggio BS. Lip implants. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2025.
  22. Talei B, Pearlman SJ. CUPID lip lift: advanced lip design using the deep plane upper lip lift and simplified corner lift. Aesthet Surg J. 2022;42(12):1357–73.
  23. Kandhari R, Goodman GJ, Signorini M, Rahman E. Use of a hyaluronic acid soft-tissue filler to correct congenital and post-traumatic lip asymmetry. J Cutan Aesthetic Surg. 2017;10(3):153–6.
  24. Hirsch P, Infanger M, Kraus A. A case of upper lip necrosis after cosmetic injection of hyaluronic acid soft-tissue filler-Does capillary infarction play a role in the development of vascular compromise, and what are the implications? J Cosmet Dermatol. 2020;19(6):1316–20.
  25. Cavallieri FA, Balassiano LKdeA, Munhoz G, Tembra MF, Wortsman X. Ultrasound in aesthetics: filler and non-filler applications. Semin Ultrasound CT MR. 2024;45(3):251–63.
  26. Kroumpouzos G, Treacy P. Hyaluronidase for dermal filler complications: review of applications and dosage recommendations. JMIR Dermatol. 2024;7:e50403.
  27. Murray G, Convery C, Walker L, Davies E. Guideline for the safe use of hyaluronidase in aesthetic medicine, including modified high-dose protocol. J Clin Aesthetic Dermatol. 2021;14(8):E69–75.
  28. Hong GW, Hu H, Chang K, et al. Review of the adverse effects associated with dermal filler treatments: part I nodules, granuloma, and migration. Diagn Basel Switz. 2024;14(15):1640.
  29. Jordan DR, Stoica B. Filler migration: a number of mechanisms to consider. Ophthal Plast Reconstr Surg. 2015;31(4):257–62.
  30. Hwang K, Jin S, Hwang SH, Chung IH. Innervation of upper orbicularis oris muscle. J Craniofac Surg. 2006;17(6):1116–7.
  31. Fundarò SP, Salti G, Malgapo DMH, Innocenti S. The rheology and physicochemical characteristics of hyaluronic acid fillers: their clinical implications. Int J Mol Sci. 2022;23(18):10518.
  32. de la Guardia C, Virno A, Musumeci M, Bernardin A, Silberberg MB. Rheologic and physicochemical characteristics of hyaluronic acid fillers: overview and relationship to product performance. Facial Plast Surg FPS. 2022;38(2):116–23.
  33. Perera GGG, Argenta DF, Caon T. The rheology of injectable hyaluronic acid hydrogels used as facial fillers: A review. Int J Biol Macromol. 2024;268(Pt 2):131880.
  34. De Boulle K, Glogau R, Kono T, et al. A review of the metabolism of 1,4-butanediol diglycidyl ether-crosslinked hyaluronic acid dermal fillers. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2013;39(12):1758–66.
  35. Akgun BS, Bostan MS, Un I, Sadak AE, Bahadori F, Eroglu MS. Physico-chemical and spectroscopic characterization of hyaluronic acid hydrogels crosslinked with 1,4-butanediol diglycidyl ether (BDDE). Int J Biol Macromol. 2025;308(Pt 2):142050.
  36. Trévidic P, Trévidic T, Imanilov A, Criollo-Lamilla G. Midface multilayering filler injection technique: understanding of the dynamic facial anatomy through a "smiling cadavers" anatomical study. Plast Reconstr Surg. 2022;149(6):1326–36.
  37. Gigliofiorito DP. Filler dinamici: una nuova frontiera per la Medicina estetica. Merz Aesthetics. 2025.
  38. Gigliofiorito DP. Filler Dinamici. Tuame. 2024.
  39. Wu J, Yin N. Detailed anatomy of the nasolabial muscle in human fetuses as determined by micro-CT combined with iodine staining. Ann Plast Surg. 2016;76(1):111–6.
  40. Scarano A, Inchingolo F, Carmine MD, et al. Dermal cosmetic migration after lip augmentation procedure: clinical management and histological analysis in a case report with review of the literature. Surgeries. 2023;4(2):223–34.
  41. Wollina U, Goldman A, Wollina U, Goldman A. Filler migration after facial injection—a narrative review. Cosmetics. 2023;10(4):115.
  42. Tansatit T, Apinuntrum P, Phetudom T. Cadaveric assessment of lip injections: locating the serious threats. Aesthetic Plast Surg. 2017;41(2):430–40.
  43. Love M, Saunders C, Harris S, Moon Z, Veale D. Redefining beauty: a qualitative study exploring adult women's motivations for lip filler resulting in anatomical distortion. Aesthet Surg J. 2023;43(8):907–16.
  44. Cazzato V, Ellis C, Makris S. "Magic cosmetic fillers": appearance-enhancement effects on self-face recognition. PLoS ONE. 2024;19(6):e0305580.

📄 下载全文PDF

标签
唇填充iLips动态填充剂透明质酸Belotero填充剂移位口轮匝肌Merz Lip Fullness ScaleFACE-Q微隧道技术

声明:中文精读 · 仅供学术参考。内容来自公开文献检索,不代表本人观点,不构成诊疗建议。 医疗美容需在正规医疗机构由执业医师实施。